Exercise and Respiratory Training Improve Exercise Capacity and Quality of Life in Patients With Severe Chronic Pulmonary Hypertension
Top Cited Papers
- 3 October 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 114 (14) , 1482-1489
- https://doi.org/10.1161/circulationaha.106.618397
Abstract
Background— Pulmonary hypertension (PH) is associated with restricted physical capacity, limited quality of life, and a poor prognosis because of right heart failure. The present study is the first prospective randomized study to evaluate the effects of exercise and respiratory training in patients with severe symptomatic PH. Methods and Results— Thirty patients with PH (21 women; mean age, 50±13 years; mean pulmonary artery pressure, 50±15 mm Hg; mean World Health Organization [WHO] class, 2.9±0.5; pulmonary arterial hypertension, n=23; chronic thromboembolic PH, n=7) on stable disease-targeted medication were randomly assigned to a control (n=15) and a primary training (n=15) group. Medication remained unchanged during the study period. Primary end points were the changes from baseline to week 15 in the distance walked in 6 minutes and in scores of the Short Form Health Survey quality-of-life questionnaire. Changes in WHO functional class, Borg scale, and parameters of echocardiography and gas exchange also were assessed. At week 15, patients in the primary and secondary training groups had an improved 6-minute walking distance; the mean difference between the control and the primary training group was 111 m (95% confidence interval, 65 to 139 m; P Conclusions— This study indicates that respiratory and physical training could be a promising adjunct to medical treatment in severe PH. The effects add to the beneficial results of modern medical treatment.Keywords
This publication has 29 references indexed in Scilit:
- Goal-oriented treatment and combination therapy for pulmonary arterial hypertensionEuropean Respiratory Journal, 2005
- The anti-inflammatory effect of exerciseJournal of Applied Physiology, 2005
- Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertensionEuropean Respiratory Journal, 2005
- Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertensionEuropean Respiratory Journal, 2004
- Anxiety and Depression in Patients With Pulmonary HypertensionPsychosomatic Medicine, 2004
- Treatment of Pulmonary Arterial HypertensionNew England Journal of Medicine, 2004
- Clinical classification of pulmonary hypertensionPublished by Elsevier ,2004
- Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoidsEuropean Respiratory Journal, 2003
- Combined endurance/resistance training reduces plasma TNF-α receptor levels in patients with chronic heart failure and coronary artery diseaseEuropean Heart Journal, 2002
- Inhaled Iloprost for Severe Pulmonary HypertensionNew England Journal of Medicine, 2002